Skip to main content
Dermot Maher, MD, Anesthesiology, Washington, DC

DermotMaherMD

Anesthesiology • Washington, DC

Pain Medicine

Physician

Join to view full profile

Dr. Maher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Maher's full profile

Already have an account?

  • Office

    Sibley Medical Building
    5215 Loughboro Road NW Suite 300
    Washington, DC 20016
    Phone+1 202-660-5191

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Pain Medicine, 2015 - 2016
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Anesthesiology, 2011 - 2015
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2011

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - Present
  • MD State Medical License
    MD State Medical License 2016 - 2025
  • DC State Medical License
    DC State Medical License 2017 - 2024
  • VA State Medical License
    VA State Medical License 2021 - 2022
  • MA State Medical License
    MA State Medical License 2015 - 2017
  • American Board of Anesthesiology Anesthesiology
  • American Board of Anesthesiology Pain Medicine

Publications & Presentations

PubMed

Press Mentions

  • One in 10 Pain Meds Make It Through Development Process
    One in 10 Pain Meds Make It Through Development ProcessJune 25th, 2022
  • New Drugs with High Abuse Potential Are More Likely to Be Approved and Go to Market to Treat Pain – Neuroscience News
    New Drugs with High Abuse Potential Are More Likely to Be Approved and Go to Market to Treat Pain – Neuroscience NewsJune 22nd, 2022
  • New Drugs with High Abuse Potential More Likely to Be Approved, Go to Market to Treat Pain
    New Drugs with High Abuse Potential More Likely to Be Approved, Go to Market to Treat PainJune 21st, 2022

Dr. Dermot Maher, Dr. Dermot Maher, MD, Dr. D Maher